Clinical spectrum and associated comorbidities of cerebral palsy among children in Eastern India Authors: Rajan Kumar, Bijit Biswas, Manoj Kumar, Deepak Kumar, Ehtesham Ansari, Soumi Kundu Published: 2025 ABSTRACT Cerebral palsy (CP) remains a leading cause of childhood disability, with varying clinical presentations and comorbidity patterns. This study explored the clinical spectrum, functional severity, and perinatal risk factors of CP among children aged 4–14 years in eastern India to identify priority areas for early intervention and support. A cross-sectional study was conducted over one year at a tertiary care centre. Data were collected through structured caregiver interviews and clinical assessments using standardized tools—the Gross Motor Function Classification System (GMFCS) and Manual Ability Classification System (MACS). Associations between demographic, perinatal, and clinical variables and CP severity were analysed using likelihood ratio tests and partial correlation analyses. Among 127 children with CP (median age: 5.9 years; 74.0% male), spastic CP was the predominant subtype (75.6%), followed by dyskinetic (9.4%), ataxic (7.9%), and mixed (7.1%) forms. Severe motor impairments (GMFCS IV–V) were present in 63.8% of participants, and manual ability severity increased proportionally with GMFCS levels (ρ = 0.702; p < 0.001). Significant correlates of severe impairment included younger age, parental age (20–29 years), high birth weight (> 4000 g), home delivery, absence of crying at birth, neonatal seizures, hypoxic–ischemic encephalopathy, and jaundice. Comorbidities were common—language (78.7%), cognitive (62.2%), and personal–social (58.3%) impairments were most frequent. Only 12.6% of children attended school; attendance was positively associated with older age, male gender, lower GMFCS and MACS levels, and absence of cognitive, language, fine-motor, personal–social impairments, and seizure history. Spastic CP was the most frequent subtype, commonly associated with severe motor limitations and multiple comorbidities that significantly restricted educational participation. Strengthening perinatal care, early screening, and multidisciplinary rehabilitation are essential to improve functional outcomes and inclusion for children with CP in resource-limited settings. Introduction Cerebral palsy (CP) is one of the most prevalent neurodevelopmental disorders in childhood, encompassing a diverse spectrum of clinical syndromes caused by injury to the developing brain1. Defined by the International Consensus of 2005, CP is characterized as a group of permanent disorders affecting posture, movement, and motor function, resulting from non-progressive abnormalities in brain development2. Beyond motor dysfunction, CP is commonly associated with a range of comorbidities, including epilepsy, musculoskeletal challenges, feeding difficulties, cognitive impairments, hearing deficits, and communication disorders3–6. Globally, cerebral palsy (CP) affects approximately 8 million children under five years of age, with the majority residing in low- and middle-income countries (LMICs) where access to early diagnosis and rehabilitation services remains limited7. The prevalence of CP varies significantly, estimated at 1.6 per 1,000 live births in high-income countries (HICs) compared to 3.4 per 1,000 in LMICs8. This disparity reflects underlying differences in healthcare infrastructure, access to antenatal and perinatal care, and socioeconomic conditions3,5,8–12. The aetiology of CP also shows regional variations7. In LMICs, it is predominantly linked to well-characterized and modifiable factors such as hypoxia-ischaemia, prenatal infections, neonatal hypoglycaemia, and hyperbilirubinemia3,4,7,13,14. Conversely, HICs have reported a shift in causative factors, with prematurity, genetic influences, and ‘unknown pathophysiologic processes’ playing a larger role5,10,15. While HICs benefit from robust population-based studies and standardized tools for CP classification, equivalent research in LMICs remains limited3–5,7,10,13–15. In India, the burden of cerebral palsy (CP) is likely to be substantial, with many cases remaining undiagnosed, particularly in regions with limited healthcare infrastructure11,15. Tribal and rural areas of eastern India, including Jharkhand, are especially affected due to systemic barriers to early diagnosis and care. Despite this, there is a lack of region-specific epidemiological data to inform policy and programmatic responses. Children with CP who present to tertiary healthcare facilities in such settings often represent the more severe or neglected cases, thereby offering valuable insights into the clinical spectrum, comorbidities, and risk factors prevalent in underserved populations. Understanding this subset is crucial for designing context-appropriate interventions and strengthening referral systems. This study seeks to fill this critical gap by examining the clinical profile of children with CP attending a tertiary healthcare centre in Jharkhand. Through a cross-sectional assessment of associated comorbidities, risk factors, and functional limitations, the study aims to inform targeted strategies for early identification, intervention, and long-term management of CP in similar low-resource settings. Methods A cross-sectional, observational study was conducted from January to December 2023 in the outpatient department (OPD) of the All India Institute of Medical Sciences (AIIMS), Deoghar, a tertiary care centre catering to Jharkhand and neighbouring states. During this period, children aged 4 to 14 years presenting with clinical features of CP, diagnosed based on the International Consensus Definition (2005)2, were enrolled after obtaining informed consent from their guardians. Children with progressive neurological disorders or neurodegenerative diseases—such as neuro-regression, metabolic encephalopathies, or suspected leukodystrophies—were excluded to preserve the non-progressive nature of CP within the study cohort. A total of 147 children with CP were evaluated during the study period, of whom 20 were excluded based on these specified criteria. The case record form (CRF) for the study was developed following an extensive review of relevant literature and in consultation with subject matter experts to ensure construct validity, criterion validity, and alignment with the study objectives. Data collection involved structured interviews with parents or accompanying caregivers to obtain detailed demographic information (age, gender, socioeconomic status), antenatal and perinatal history, birth details, and relevant medical history, including co-morbidities. Clinical evaluation included systematic motor assessments and classification of cerebral palsy (CP) subtypes into spastic, dyskinetic, ataxic, and mixed categories, based on established diagnostic criteria. Cognitive function was assessed using the Denver Developmental Screening Test II (DDST-II)16,17, a validated tool that evaluates development across four domains: personal-social, fine motor-adaptive, language, and gross motor skills. For this study, cognitive delay was defined as a delay in any of the three domains most relevant to cognitive development—language, personal-social, or fine motor-adaptive—based on age-specific milestones. The DDST-II classification system (Normal, Suspect, Untestable) was applied, and only children with definitive delay—failing items beyond the 90th percentile age line—were categorized as delayed. Cases labelled as ‘suspect’ were re-evaluated, and final classification was based on expert consensus. Screening results were independently reviewed by two experienced paediatric specialists, and a child was classified as having cognitive delay only when both experts reached a consensus that the child’s performance was significantly below expected norms for their chronological age, thereby enhancing diagnostic objectivity and clinical validity. Language development and behavioural parameters were also assessed using the DDST-II, but only findings from the language, personal-social, and fine motor-adaptive domains were analysed, as these best reflect cognitive and adaptive functioning. Gross motor findings were excluded from subgroup analysis due to uniformly expected delays in this CP cohort. Exclusion criteria were rigorously applied: children with a documented history of neuro-regression, suspected degenerative brain disease, or recurrent episodes of metabolic decompensation—indicating possible underlying metabolic or progressive neurological disorders—were excluded post-evaluation to maintain diagnostic specificity and ensure homogeneity of the study population. Approximately 90% of participants were tertiary referrals from other healthcare facilities. The Gross Motor Function Classification System (GMFCS)18 and Manual Ability Classification System (MACS)19 were employed to assess motor and functional abilities. Given that both tools are validated for children aged 4 years and above, the study included participants aged 4 to 14 years for these assessments. Scoring was performed according to standardized protocols, and a consistent pattern was observed whereby higher GMFCS scores tended to correlate with higher MACS scores, reflecting the expected association between gross motor impairment and manual ability limitations. All clinical assessments were performed by trained consultants from the Departments of Pediatrics and Physical Medicine and Rehabilitation (PMR), with support from senior residents, ensuring consistency and adherence to protocol. The collected data were entered into Microsoft Excel (version 2021) and analyzed using JAMOVI (version 2.3.26). Categorical variables were summarized as frequencies and percentages with 95% confidence intervals (CI), and continuous variables were expressed as medians with interquartile ranges (IQR). Descriptive results were presented using simple and cross-tabulations and visualized through clustered and stacked column charts. In the univariate analysis, associations between categorical variables were examined using the likelihood ratio test. Variables showing statistical significance (p < 0.05) were further assessed in the multivariable analysis using partial correlation tests, adjusting for potential confounding factors such as demographic, parental, antenatal, perinatal, and functional parameters. The correlation coefficient (ρ) was used to measure the strength of association between variables. Statistical significance was defined as p < 0.05. Results The study participants ranged in age from 4 to 14 years, with a median age of 5.9 years. A majority (74.0%) were male and resided in rural areas (66.9%). Approximately one-fifth (22.8%) had a birth weight below 2500 g. Around one-fifth of mothers (19.7%) and one-eighth of fathers (12.8%) were illiterate, while most had at least primary education. The vast majority of children (87.4%) were not attending school. Most parents were aged 20–29 years at the time of the child’s birth—59.1% of fathers and 70.9% of mothers. Among mothers, 84.3% had received antenatal care, and 81.9% delivered vaginally. The most common antenatal risk factors were bleeding (10.2%), infection (9.4%), and diabetes (6.3%). At birth, 77.2% of infants did not cry immediately, and 78.7% required NICU admission. The leading indications for NICU admission were hypoxic-ischemic encephalopathy (HIE, 71.7%), seizures (29.9%), respiratory distress (26.0%), and jaundice (22.0%). Spastic cerebral palsy was the most frequent type (75.6%), followed by dyskinetic (9.4%), ataxic (7.9%), and mixed (7.1%) subtypes. Post-neonatal complications were common—language impairment (78.7%), cognitive impairment (62.2%), and personal-social impairment (58.3%) were the most prevalent (Table 1). Table 1Background characteristics of the study population: (n = 127).CharacteristicsValuesAge of child, y, median [IQR]5.9 [4.9; 7.0]Gender, n [%;(95% CI)]Male94 [74.0; (65.8–80.7)]Female33 [26.0; (19.1–34.2)]Birth weight, g, n [%;(95% CI)]< 250029 [22.8; (16.4–30.9)]2500–400073 [57.5; (48.8–65.7)]> 400025 [19.7; (13.7–27.4)]Attending school, n [%;(95% CI)]Ordinary12 [9.4; (5.5–15.8)]Specialised school4 [3.1; (1.2–7.8)]No schooling111 [87.4; (80.5–92.1)]Residence, n [%;(95% CI)]Rural85 [66.9; (58.4–74.5)]Urban42 [33.1; (25.5–41.6)]Fathers level of education, n [%;(95% CI)]Not educated16 [12.6; (7.9–19.5)]Up to Primary24 [18.9; (13.0–26.6.0.6)]Middle24 [18.9; (13.0–26.6.0.6)]High school28 [22.0; (15.7–30.0)]Graduate and above35 [27.6; (20.5–35.9)]Mothers level of education, n [%;(95% CI)]Not educated25 [19.7; (13.7–27.5)]Up to Primary27 [21.3; (15.0–29.2.0.2)]Middle32 [25.2; (18.5–33.4)]High school19 [15.0; (9.8–22.2)]Intermediate8 [6.3; (3.2–11.9)]Graduate and above16 [12.6; (7.9–19.5)]Fathers age at delivery, y, n [%;(95% CI)]< 204 [3.1; (1.2–7.8)]20–2975 [59.1; (50.4–67.2)]30–3943 [33.9; (26.2–42.5)]≥ 405 [3.9; (1.7–8.9)]Maternal age at delivery, y, n [%;(95% CI)]< 2035 [27.6; (20.5–35.9)]20–2990 [70.9; (62.4–78.1)]30–392 [1.6; (0.4–5.6)]Received antenatal care, n [%;(95% CI)]107 [84.3; (76.9–89.6)]Risk factors during pregnancy, n [%;(95% CI)]Hypertension6 [4.7; (2.2–9.9)]Diabetes8 [6.3; (3.2–11.9)]Infection12 [9.4; (5.5–15.8)]Bleeding13 [10.2; (6.1–16.7)]Substance abuse5 [3.9; (1.7–8.9)]No risk83 [65.4; (56.7–73.1)]History of birth delivery, n [%;(95% CI)]Obstructed labor41 [32.3; (24.8–40.8)]Prolonged labor86 [67.7, (59.2–75.2)]Normal vaginal delivery104 [81.9; (74.3–87.6)]Caesarean section23 [18.1; (12.4–25.7)]Not crying at birth, n [%;(95% CI)]98 [77.2; (69.2–83.6)]Admitted into NICU, n [%;(95% CI)]100 [78.7; (70.8–85.0)]Indication of NICU admission, n [%;(95% CI)]HIE91 [71.7; (63.8–78.8)]Jaundice28 [22.0; (15.7–30.0)]Sepsis26 [20.5; (14.4–28.3)]Seizures at birth38 [29.9; (22.6–38.4)]Breathing difficulty33 [26.0; (19.1–34.2)]Post neonatal events, n [%;(95% CI)]Language impairment100 [78.7; (70.8–85.0)]Food habit impairment36 [28.3; (21.2–36.7)]Behavioural issue26 [20.5; (14.4–28.3)]Seizure/convulsions58 [45.7; (37.3–54.3)]Cognitive impairment79 [62.2; (53.5–70.2)]Type of cerebral palsy, n [%;(95% CI)]Spastic96 [75.6; (67.4–82.2)]Dyskinetic12 [9.4; (5.5–15.8)]Ataxic10 [7.9; (4.3–13.9)]Mixed9 [7.1, (3.8–12.9)]y Years, IQR Interquartile range [25th percentile; 75th percentile], NICU Neonatal intensive care unit, CI Confidence interval, HIE Hypoxic ischaemic encephalopathy. Table 1Background characteristics of the study population: (n = 127).CharacteristicsValuesAge of child, y, median [IQR]5.9 [4.9; 7.0]Gender, n [%;(95% CI)]Male94 [74.0; (65.8–80.7)]Female33 [26.0; (19.1–34.2)]Birth weight, g, n [%;(95% CI)]< 250029 [22.8; (16.4–30.9)]2500–400073 [57.5; (48.8–65.7)]> 400025 [19.7; (13.7–27.4)]Attending school, n [%;(95% CI)]Ordinary12 [9.4; (5.5–15.8)]Specialised school4 [3.1; (1.2–7.8)]No schooling111 [87.4; (80.5–92.1)]Residence, n [%;(95% CI)]Rural85 [66.9; (58.4–74.5)]Urban42 [33.1; (25.5–41.6)]Fathers level of education, n [%;(95% CI)]Not educated16 [12.6; (7.9–19.5)]Up to Primary24 [18.9; (13.0–26.6.0.6)]Middle24 [18.9; (13.0–26.6.0.6)]High school28 [22.0; (15.7–30.0)]Graduate and above35 [27.6; (20.5–35.9)]Mothers level of education, n [%;(95% CI)]Not educated25 [19.7; (13.7–27.5)]Up to Primary27 [21.3; (15.0–29.2.0.2)]Middle32 [25.2; (18.5–33.4)]High school19 [15.0; (9.8–22.2)]Intermediate8 [6.3; (3.2–11.9)]Graduate and above16 [12.6; (7.9–19.5)]Fathers age at delivery, y, n [%;(95% CI)]< 204 [3.1; (1.2–7.8)]20–2975 [59.1; (50.4–67.2)]30–3943 [33.9; (26.2–42.5)]≥ 405 [3.9; (1.7–8.9)]Maternal age at delivery, y, n [%;(95% CI)]< 2035 [27.6; (20.5–35.9)]20–2990 [70.9; (62.4–78.1)]30–392 [1.6; (0.4–5.6)]Received antenatal care, n [%;(95% CI)]107 [84.3; (76.9–89.6)]Risk factors during pregnancy, n [%;(95% CI)]Hypertension6 [4.7; (2.2–9.9)]Diabetes8 [6.3; (3.2–11.9)]Infection12 [9.4; (5.5–15.8)]Bleeding13 [10.2; (6.1–16.7)]Substance abuse5 [3.9; (1.7–8.9)]No risk83 [65.4; (56.7–73.1)]History of birth delivery, n [%;(95% CI)]Obstructed labor41 [32.3; (24.8–40.8)]Prolonged labor86 [67.7, (59.2–75.2)]Normal vaginal delivery104 [81.9; (74.3–87.6)]Caesarean section23 [18.1; (12.4–25.7)]Not crying at birth, n [%;(95% CI)]98 [77.2; (69.2–83.6)]Admitted into NICU, n [%;(95% CI)]100 [78.7; (70.8–85.0)]Indication of NICU admission, n [%;(95% CI)]HIE91 [71.7; (63.8–78.8)]Jaundice28 [22.0; (15.7–30.0)]Sepsis26 [20.5; (14.4–28.3)]Seizures at birth38 [29.9; (22.6–38.4)]Breathing difficulty33 [26.0; (19.1–34.2)]Post neonatal events, n [%;(95% CI)]Language impairment100 [78.7; (70.8–85.0)]Food habit impairment36 [28.3; (21.2–36.7)]Behavioural issue26 [20.5; (14.4–28.3)]Seizure/convulsions58 [45.7; (37.3–54.3)]Cognitive impairment79 [62.2; (53.5–70.2)]Type of cerebral palsy, n [%;(95% CI)]Spastic96 [75.6; (67.4–82.2)]Dyskinetic12 [9.4; (5.5–15.8)]Ataxic10 [7.9; (4.3–13.9)]Mixed9 [7.1, (3.8–12.9)]y Years, IQR Interquartile range [25th percentile; 75th percentile], NICU Neonatal intensive care unit, CI Confidence interval, HIE Hypoxic ischaemic encephalopathy. Background characteristics of the study population: (n = 127). y Years, IQR Interquartile range [25th percentile; 75th percentile], NICU Neonatal intensive care unit, CI Confidence interval, HIE Hypoxic ischaemic encephalopathy. In the study cohort, a substantial proportion of children exhibited severe functional limitations—63.8% were classified as GMFCS IV–V and 45.0% as MACS IV–V (Fig. 1A). The severity of manual ability increased progressively with higher GMFCS levels (likelihood ratio = 167.1; df = 16; p < 0.001). After controlling for demographic (age, sex, residence), parental (age and education), antenatal, perinatal, and delivery factors—including birth weight, gestational age, high-risk pregnancy status, adverse neonatal events (crying status, HIE, jaundice, sepsis, seizures, and breathing difficulty), place and mode of delivery, NICU admission, and cerebral palsy type—GMFCS and MACS scores remained positively correlated (ρ = 0.702; p < 0.001) (Fig. 1B). Spastic cerebral palsy predominated among children with severe gross motor impairment, whereas dyskinetic cerebral palsy was more frequent among those with severe manual impairment (likelihood ratio = 29.99; df = 12; p = 0.003). After adjusting for demographic, perinatal, and delivery variables, GMFCS levels showed a negative correlation with cerebral palsy type (ρ = − 0.225; p = 0.026) (Fig. 1C). A significant association was also observed between age and GMFCS levels, with younger children exhibiting greater impairment (likelihood ratio = 49.4; df = 12; p < 0.001). After adjustment for demographic, parental, perinatal, developmental, and functional parameters—including MACS levels—GMFCS showed a negative correlation with age (ρ = − 0.248; p = 0.014) (Fig. 1D). Furthermore, the proportion of severely affected children decreased with age (likelihood ratio = 31.2; df = 3; p < 0.001). When controlling for the same covariates, overall disease severity showed a negative but non-significant correlation with age (ρ = − 0.106; p = 0.300) (Fig. 2). On univariate analysis, factors significantly associated with severe motor impairment (GMFCS IV–V) included parental age 20–29 years (p = 0.033), high birth weight > 4000 g (p < 0.001), home delivery (p = 0.025), absence of crying at birth (p = 0.014), seizures at birth (p = 0.001), and presence of HIE (p = 0.014). No significant associations were observed with residence (p = 0.052), antenatal care (p = 0.435), gestational age (p = 0.152), labor complications (p = 0.224), NICU admission (p = 0.150), breathing difficulty (p = 0.191), or sepsis (p = 0.477). In multivariable analysis adjusted for age and sex, higher paternal education correlated positively with GMFCS severity (ρ = 0.338; p < 0.001), whereas high-risk pregnancy correlated negatively (ρ = − 0.261; p = 0.003). Birth weight (ρ = 0.275; p = 0.002), HIE (ρ = 0.230; p = 0.010), and NICU admission (ρ = 0.283; p = 0.001) were also positively correlated (Table 2). Table 2Risk factors associated with motor outcome (GMFCS Levels) in the study participants with cerebral palsy: (n = 127).AttributesGMFCS (% of variables)Likelihood ratio test*Partial correlation test#IIIIIIIVVAge of the mother, y:< 207 (20.0)4 (11.4)7 (20.0)2 (5.7)15 (42.9)LR (df) = 27.66 (8), p = 0.001ρ = 0.152,p = 0.09120–292 (2.2)18 (20.0)8 (8.9)28 (31.1)34 (37.8)30–390 (0.0)0 (0.0)0 (0.0)2 (100.0)0 (0.0)Age of the father, y:< 200 (0.0)2 (50.0)0 (0.0)0 (0.0)2 (50.0)LR (df) = 22.42 (12), p = 0.033ρ = −0.089, p = 0.32320–294 (5.3)7 (9.3)12 (16.0)23 (30.7)29 (38.7)30–395 (11.6)13 (30.2)3 (7.0)7 (16.3)15 (34.9)≥ 400 (0.0)0 (0.0)0 (0.0)2 (40.0)3 (60.0)Mothers educational level:Illiterate5 (20.0)0 (0.0)5 (20.0)7 (28.0)8 (32.0)LR (df) = 17.29 (4), p = 0.002ρ = 0.136, p = 0.130Literate4 (3.9)22 (21.6)10 (9.8)25 (24.5)41 (40.2)Fathers educational level:Illiterate5 (31.3)2 (12.5)3 (18.8)3 (18.8)3 (18.8)LR (df) = 12.92 (4), p = 0.012ρ = 0.338, p = < 0.001Literate4 (3.6)20 (18.0)12 (10.8)29 (26.1)46 (41.4)Residence:Rural7 (8.2)10 (11.8)8 (9.4)26 (30.6)34 (40.0)LR (df) = 9.38 (4), p = 0.052ρ = −0.082,p = 0.361Urban2 (4.8)12 (28.6)7 (16.7)6 (14.3)15 (35.7)Received antenatal care:No2 (10.0)2 (10.0)2 (10.0)3 (15.0)11 (55.0)LR (df) = 3.79 (4), p = 0.435ρ = 0.089, p = 0.326Yes7 (6.5)20 (18.7)13 (12.1)29 (27.1)38 (35.5)Gestational age:Preterm0 (0.0)2 (14.3)5 (35.7)2 (14.3)5 (35.7)LR (df) = 11.98 (8), p = 0.152ρ = −0.036, p = 0.690Term9 (9.5)17 (17.9)8 (8.4)24 (25.3)37 (38.9)Post term0 (0.0)3 (16.7)2 (11.1)6 (33.3)7 (38.9)High risk Pregnancy:No6 (7.2)11 (13.3)4 (4.8)27 (32.5)35 (42.2)LR (df) = 18.17 (4), p = 0.001ρ = −0.261, p = 0.003Yes3 (6.8)11 (25.0)11 (25.0)5 (11.4)14 (31.8)Complications in labor:Obstructed2 (4.9)4 (9.8)3 (7.3)13 (31.7)19 (46.3)LR (df) = 5.69 (4), p = 0.224ρ = −0.079, p = 0.380Prolonged7 (8.1)18 (20.9)12 (14.0)19 (22.1)30 (34.9)Place of delivery:Hospital9 (8.0)17 (15.0)15 (13.3)26 (23.0)46 (40.7)LR (df) = 9.19 (4), p = 0.025ρ = −0.011, p = 0.907Home0 (0.0)5 (35.7)0 (0.0)6 (42.9)3 (21.4)Mode of delivery:Vaginal7 (6.7)22 (21.2)13 (12.5)24 (23.1)38 (36.5)LR (df) = 10.66 (4), p = 0.031ρ = 0.072, p = 0.424Caesarean2 (8.7)0 (0.0)2 (8.7)8 (34.8)11 (47.8)Birth weight, g:< 25004 (13.8)7 (24.1)7 (24.1)9 (31.0)2 (6.9)LR (df) = 47.52 (8), p = < 0.001ρ = 0.275, p = 0.0022500–40005 (6.8)15 (20.5)8 (11.0)10 (13.7)35 (47.9)> 40000 (0.0)0 (0.0)0 (0.0)13 (52.0)12 (48.0)Crying at birth:No4 (4.1)18 (18.4)8 (8.2)25 (25.5)43 (43.9)LR (df) = 12.46 (4), p = 0.014ρ = 0.122, p = 0.174Yes5 (17.2)4 (13.8)7 (24.1)7 (24.1)6 (20.7)Seizure at birth:No5 (5.6)20 (22.5)4 (4.5)22 (24.7)38 (42.7)LR (df) = 19.88 (4), p = 0.001ρ = 0.062, p = 0.493Yes4 (10.5)2 (5.3)11 (28.9)10 (26.3)11 (28.9)Breathing difficulty at birth:No7 (7.4)14 (14.9)12 (12.8)28 (29.8)33 (35.1)LR (df) = 6.11 (4), p = 0.191ρ = 0.118, p = 0.190Yes2 (6.1)8 (24.2)3 (9.1)4 (12.1)16 (48.5)HIE at birth:No3 (8.3)11 (30.6)7 (19.4)8 (22.2)7 (19.4)LR (df) = 12.57 (4), p = 0.014ρ = 0.230, p = 0.010Yes6 (6.6)11 (12.1)8 (8.8)24 (26.4)42 (46.2)Jaundice at birth:No7 (7.1)18 (18.2)6 (6.1)25 (25.3)43 (43.4)LR (df) = 13.34 (4), p = 0.010ρ = 0.029, p = 0.747Yes2 (7.1)4 (14.3)9 (32.1)7 (25.0)6 (21.4)Sepsis at birth:No7 (6.9)20 (19.8)10 (9.9)25 (24.8)39 (38.6)LR (df) = 3.50 (4), p = 0.477ρ = 0.136, p = 0.130Yes2 (7.7)2 (7.7)5 (19.2)7 (26.9)10 (38.5)Admission to NICU:No3 (11.1)7 (25.9)4 (14.8)8 (29.6)5 (18.5)LR (df) = 6.75 (4), p = 0.150ρ = 0.283, p = 0.001Yes6 (6.0)15 (15.0)11 (11.0)24 (24.0)44 (44.0)*Univariate analysis. #Multivariable analysis adjusted for age and sex of the child. ρ = Correlation Co-Efficient. y Years, NICU Neonatal intensive care unit, g Grams, HIE Hypoxic ischaemic encephalopathy. Table 2Risk factors associated with motor outcome (GMFCS Levels) in the study participants with cerebral palsy: (n = 127).AttributesGMFCS (% of variables)Likelihood ratio test*Partial correlation test#IIIIIIIVVAge of the mother, y:< 207 (20.0)4 (11.4)7 (20.0)2 (5.7)15 (42.9)LR (df) = 27.66 (8), p = 0.001ρ = 0.152,p = 0.09120–292 (2.2)18 (20.0)8 (8.9)28 (31.1)34 (37.8)30–390 (0.0)0 (0.0)0 (0.0)2 (100.0)0 (0.0)Age of the father, y:< 200 (0.0)2 (50.0)0 (0.0)0 (0.0)2 (50.0)LR (df) = 22.42 (12), p = 0.033ρ = −0.089, p = 0.32320–294 (5.3)7 (9.3)12 (16.0)23 (30.7)29 (38.7)30–395 (11.6)13 (30.2)3 (7.0)7 (16.3)15 (34.9)≥ 400 (0.0)0 (0.0)0 (0.0)2 (40.0)3 (60.0)Mothers educational level:Illiterate5 (20.0)0 (0.0)5 (20.0)7 (28.0)8 (32.0)LR (df) = 17.29 (4), p = 0.002ρ = 0.136, p = 0.130Literate4 (3.9)22 (21.6)10 (9.8)25 (24.5)41 (40.2)Fathers educational level:Illiterate5 (31.3)2 (12.5)3 (18.8)3 (18.8)3 (18.8)LR (df) = 12.92 (4), p = 0.012ρ = 0.338, p = < 0.001Literate4 (3.6)20 (18.0)12 (10.8)29 (26.1)46 (41.4)Residence:Rural7 (8.2)10 (11.8)8 (9.4)26 (30.6)34 (40.0)LR (df) = 9.38 (4), p = 0.052ρ = −0.082,p = 0.361Urban2 (4.8)12 (28.6)7 (16.7)6 (14.3)15 (35.7)Received antenatal care:No2 (10.0)2 (10.0)2 (10.0)3 (15.0)11 (55.0)LR (df) = 3.79 (4), p = 0.435ρ = 0.089, p = 0.326Yes7 (6.5)20 (18.7)13 (12.1)29 (27.1)38 (35.5)Gestational age:Preterm0 (0.0)2 (14.3)5 (35.7)2 (14.3)5 (35.7)LR (df) = 11.98 (8), p = 0.152ρ = −0.036, p = 0.690Term9 (9.5)17 (17.9)8 (8.4)24 (25.3)37 (38.9)Post term0 (0.0)3 (16.7)2 (11.1)6 (33.3)7 (38.9)High risk Pregnancy:No6 (7.2)11 (13.3)4 (4.8)27 (32.5)35 (42.2)LR (df) = 18.17 (4), p = 0.001ρ = −0.261, p = 0.003Yes3 (6.8)11 (25.0)11 (25.0)5 (11.4)14 (31.8)Complications in labor:Obstructed2 (4.9)4 (9.8)3 (7.3)13 (31.7)19 (46.3)LR (df) = 5.69 (4), p = 0.224ρ = −0.079, p = 0.380Prolonged7 (8.1)18 (20.9)12 (14.0)19 (22.1)30 (34.9)Place of delivery:Hospital9 (8.0)17 (15.0)15 (13.3)26 (23.0)46 (40.7)LR (df) = 9.19 (4), p = 0.025ρ = −0.011, p = 0.907Home0 (0.0)5 (35.7)0 (0.0)6 (42.9)3 (21.4)Mode of delivery:Vaginal7 (6.7)22 (21.2)13 (12.5)24 (23.1)38 (36.5)LR (df) = 10.66 (4), p = 0.031ρ = 0.072, p = 0.424Caesarean2 (8.7)0 (0.0)2 (8.7)8 (34.8)11 (47.8)Birth weight, g:< 25004 (13.8)7 (24.1)7 (24.1)9 (31.0)2 (6.9)LR (df) = 47.52 (8), p = < 0.001ρ = 0.275, p = 0.0022500–40005 (6.8)15 (20.5)8 (11.0)10 (13.7)35 (47.9)> 40000 (0.0)0 (0.0)0 (0.0)13 (52.0)12 (48.0)Crying at birth:No4 (4.1)18 (18.4)8 (8.2)25 (25.5)43 (43.9)LR (df) = 12.46 (4), p = 0.014ρ = 0.122, p = 0.174Yes5 (17.2)4 (13.8)7 (24.1)7 (24.1)6 (20.7)Seizure at birth:No5 (5.6)20 (22.5)4 (4.5)22 (24.7)38 (42.7)LR (df) = 19.88 (4), p = 0.001ρ = 0.062, p = 0.493Yes4 (10.5)2 (5.3)11 (28.9)10 (26.3)11 (28.9)Breathing difficulty at birth:No7 (7.4)14 (14.9)12 (12.8)28 (29.8)33 (35.1)LR (df) = 6.11 (4), p = 0.191ρ = 0.118, p = 0.190Yes2 (6.1)8 (24.2)3 (9.1)4 (12.1)16 (48.5)HIE at birth:No3 (8.3)11 (30.6)7 (19.4)8 (22.2)7 (19.4)LR (df) = 12.57 (4), p = 0.014ρ = 0.230, p = 0.010Yes6 (6.6)11 (12.1)8 (8.8)24 (26.4)42 (46.2)Jaundice at birth:No7 (7.1)18 (18.2)6 (6.1)25 (25.3)43 (43.4)LR (df) = 13.34 (4), p = 0.010ρ = 0.029, p = 0.747Yes2 (7.1)4 (14.3)9 (32.1)7 (25.0)6 (21.4)Sepsis at birth:No7 (6.9)20 (19.8)10 (9.9)25 (24.8)39 (38.6)LR (df) = 3.50 (4), p = 0.477ρ = 0.136, p = 0.130Yes2 (7.7)2 (7.7)5 (19.2)7 (26.9)10 (38.5)Admission to NICU:No3 (11.1)7 (25.9)4 (14.8)8 (29.6)5 (18.5)LR (df) = 6.75 (4), p = 0.150ρ = 0.283, p = 0.001Yes6 (6.0)15 (15.0)11 (11.0)24 (24.0)44 (44.0)*Univariate analysis. #Multivariable analysis adjusted for age and sex of the child. ρ = Correlation Co-Efficient. y Years, NICU Neonatal intensive care unit, g Grams, HIE Hypoxic ischaemic encephalopathy. Risk factors associated with motor outcome (GMFCS Levels) in the study participants with cerebral palsy: (n = 127). ρ = 0.152, p = 0.091 ρ = −0.082, p = 0.361 *Univariate analysis. #Multivariable analysis adjusted for age and sex of the child. ρ = Correlation Co-Efficient. y Years, NICU Neonatal intensive care unit, g Grams, HIE Hypoxic ischaemic encephalopathy. On univariate analysis, school attendance was significantly associated with older age (p < 0.001), male gender (p = 0.001), and lower GMFCS and MACS levels (both p < 0.001). Children without cognitive (p = 0.001), language (p < 0.001), fine-motor (p = 0.001), personal-social (p = 0.037), or seizure impairments (p = 0.002) were more likely to attend school. All school-going children had spastic CP (p = 0.022). No associations were observed with residence (p = 0.690), dietary habit impairment (p = 0.107), behavioural issues (p = 0.854), or parental literacy (p > 0.05 for both). In multivariable analysis, adjusted for gestational age, birth weight, antenatal care, high-risk pregnancy, delivery characteristics, and neonatal complications, school attendance correlated positively with age (ρ = 0.482; p < 0.001) and parental education (father ρ = 0.277; p = 0.003; mother ρ = 0.214; p = 0.023), and negatively with GMFCS (ρ = − 0.425; p < 0.001), MACS (ρ = − 0.340; p < 0.001), and language impairment (ρ = − 0.355; p < 0.001) (Table 3). Table 3Distribution of schooled children with cerebral palsy according to their demographic and clinical characteristics: (n = 127).VariablesSchooled (% in variables)Likelihood Ratio Test*Partial Correlation Test#Age of child, y:LR (df) = 51.77 (3), p = < 0.001ρ = 0.482, p = < 0.0014–52/68 (2.9)6–70/36 (0.0)8–92/7 (28.6)≥ 1012/16 (75.0)Sex:LR (df) = 10.41 (1), p = 0.001ρ = 0.058, p = 0.540Male16/94 (17.0)Female0/33 (0.0)Residence:LR (df) = 0.16 (1), p = 0.690ρ = −0.102, p = 0.282Rural10/85 (11.8)Urban6/42 (14.3)Fathers’ education level:LR (df) = 2.15 (1), p = 0.143ρ = 0.277, p = 0.003Illiterate4/16 (25.0)Literate12/111 (10.8)Mothers’ education level:LR (df) = 0.65 (1), p = 0.418ρ = 0.214, p = 0.023Illiterate2/25 (8.0)Literate14/102 (13.7)MACS:LR (df) = 38.84 (4), p = < 0.001ρ = −0.340, p = < 0.001MACS I6/19 (31.6)MACS II10/25 (40.0)MACS III0/26 (0.0)MACS IV0/18 (0.0)MACS V0/39 (0.0)GMFCS:LR (df) = 41.14 (4), p = < 0.001ρ = −0.425, p = < 0.001GMFCS I2/9 (22.2)GMFCS II11/22 (50.0)GMFCS III3/15 (20.0)GMFCS IV0/32 (0.0)GMFCS V0/49 (0.0)Cognitive impairment:LR (df) = 10.54 (1), p = 0.001ρ = −0.049, p = 0.608Yes4/79 (5.1)No12/48 (25.0)Language impairment: **LR (df) = 25.5 (1), p = < 0.001ρ = −0.355, p = < 0.001Yes4/100 (4.0)No12/27 (44.4)Fine motor impairment: **LR (df) = 11.55 (1), p = 0.001ρ = −0.101, p = 0.289Yes3/73 (4.1)No13/54 (24.1)Personal Social impairment: **LR (df) = 4.34 (1), p = 0.037ρ = −0.041, p = 0.670Yes3/53 (5.7)No13/74 (17.6)Food habit impairment:LR (df) = 2.60 (1), p = 0.107ρ = −0.205, p = 0.029Yes2/36 (5.6)No14/91 (15.4)Behavioural issue:LR (df) = 0.03 (1), p = 0.854ρ = −0.125, p = 0.188Yes3/26 (11.5)No13/101 (12.9)Seizures:LR (df) = 9.18 (1), p = 0.002ρ = −0.181, p = 0.054Yes2/58 (3.4)No14/69 (20.3)Type of cerebral palsy:LR (df) = 9.68 (3), p = 0.022ρ = −0.015, p = 0.874Spastic16/96 (16.7)Dyskinetic0/12 (0.0)Ataxic0/10 (0.0)Mixed0/9 (0.0)*Univariate analysis. # Multivariable analysis adjusted for gestational age, birth weight, receipt of antenatal care (ANC), high-risk pregnancy status, place of delivery, complications during labor, mode of delivery, crying immediately after birth, hypoxic-ischemic encephalopathy (HIE) at birth, neonatal jaundice, neonatal sepsis, neonatal seizures, breathing difficulty at birth, and admission to the neonatal intensive care unit (NICU). **assessed by Denver Developmental Screening Test II. ρ = Correlation Co-Efficient. y Years, GMFCS Gross motor function classification system, MACS Manual ability classification system. Table 3Distribution of schooled children with cerebral palsy according to their demographic and clinical characteristics: (n = 127).VariablesSchooled (% in variables)Likelihood Ratio Test*Partial Correlation Test#Age of child, y:LR (df) = 51.77 (3), p = < 0.001ρ = 0.482, p = < 0.0014–52/68 (2.9)6–70/36 (0.0)8–92/7 (28.6)≥ 1012/16 (75.0)Sex:LR (df) = 10.41 (1), p = 0.001ρ = 0.058, p = 0.540Male16/94 (17.0)Female0/33 (0.0)Residence:LR (df) = 0.16 (1), p = 0.690ρ = −0.102, p = 0.282Rural10/85 (11.8)Urban6/42 (14.3)Fathers’ education level:LR (df) = 2.15 (1), p = 0.143ρ = 0.277, p = 0.003Illiterate4/16 (25.0)Literate12/111 (10.8)Mothers’ education level:LR (df) = 0.65 (1), p = 0.418ρ = 0.214, p = 0.023Illiterate2/25 (8.0)Literate14/102 (13.7)MACS:LR (df) = 38.84 (4), p = < 0.001ρ = −0.340, p = < 0.001MACS I6/19 (31.6)MACS II10/25 (40.0)MACS III0/26 (0.0)MACS IV0/18 (0.0)MACS V0/39 (0.0)GMFCS:LR (df) = 41.14 (4), p = < 0.001ρ = −0.425, p = < 0.001GMFCS I2/9 (22.2)GMFCS II11/22 (50.0)GMFCS III3/15 (20.0)GMFCS IV0/32 (0.0)GMFCS V0/49 (0.0)Cognitive impairment:LR (df) = 10.54 (1), p = 0.001ρ = −0.049, p = 0.608Yes4/79 (5.1)No12/48 (25.0)Language impairment: **LR (df) = 25.5 (1), p = < 0.001ρ = −0.355, p = < 0.001Yes4/100 (4.0)No12/27 (44.4)Fine motor impairment: **LR (df) = 11.55 (1), p = 0.001ρ = −0.101, p = 0.289Yes3/73 (4.1)No13/54 (24.1)Personal Social impairment: **LR (df) = 4.34 (1), p = 0.037ρ = −0.041, p = 0.670Yes3/53 (5.7)No13/74 (17.6)Food habit impairment:LR (df) = 2.60 (1), p = 0.107ρ = −0.205, p = 0.029Yes2/36 (5.6)No14/91 (15.4)Behavioural issue:LR (df) = 0.03 (1), p = 0.854ρ = −0.125, p = 0.188Yes3/26 (11.5)No13/101 (12.9)Seizures:LR (df) = 9.18 (1), p = 0.002ρ = −0.181, p = 0.054Yes2/58 (3.4)No14/69 (20.3)Type of cerebral palsy:LR (df) = 9.68 (3), p = 0.022ρ = −0.015, p = 0.874Spastic16/96 (16.7)Dyskinetic0/12 (0.0)Ataxic0/10 (0.0)Mixed0/9 (0.0)*Univariate analysis. # Multivariable analysis adjusted for gestational age, birth weight, receipt of antenatal care (ANC), high-risk pregnancy status, place of delivery, complications during labor, mode of delivery, crying immediately after birth, hypoxic-ischemic encephalopathy (HIE) at birth, neonatal jaundice, neonatal sepsis, neonatal seizures, breathing difficulty at birth, and admission to the neonatal intensive care unit (NICU). **assessed by Denver Developmental Screening Test II. ρ = Correlation Co-Efficient. y Years, GMFCS Gross motor function classification system, MACS Manual ability classification system. Distribution of schooled children with cerebral palsy according to their demographic and clinical characteristics: (n = 127). *Univariate analysis. # Multivariable analysis adjusted for gestational age, birth weight, receipt of antenatal care (ANC), high-risk pregnancy status, place of delivery, complications during labor, mode of delivery, crying immediately after birth, hypoxic-ischemic encephalopathy (HIE) at birth, neonatal jaundice, neonatal sepsis, neonatal seizures, breathing difficulty at birth, and admission to the neonatal intensive care unit (NICU). **assessed by Denver Developmental Screening Test II. ρ = Correlation Co-Efficient. y Years, GMFCS Gross motor function classification system, MACS Manual ability classification system. On univariate analysis, language impairment was most common among children aged < 10 years (p = 0.001). Cognitive impairment, seizures, and food-habit difficulties declined with age (all p < 0.001), whereas fine-motor and personal-social impairments increased (p < 0.001 and p = 0.006, respectively). No clear age-related trend was seen for language or behavioural issues (p = 0.034). Cognitive impairment increased with GMFCS severity (p < 0.001). No cases of cognitive impairment, seizures, food-habit, or behavioural issues occurred among children with GMFCS I. Behavioural problems were significantly associated with CP type (p = 0.001) and seen exclusively in spastic CP, while food-habit impairment was confined to spastic and dyskinetic types (p < 0.001). Language impairment was the most frequent comorbidity, followed by cognitive impairment and seizures (p = 0.008 and p = 0.006, respectively). In multivariable analysis, adjusted for demographic, parental, perinatal, and functional variables, fine-motor (ρ = 0.278; p = 0.004), personal-social (ρ = 0.203; p = 0.039), cognitive (ρ = 0.367; p < 0.001), and food-habit impairments (ρ = 0.257; p = 0.008) were positively correlated with GMFCS levels, while seizures were positively correlated with CP type (ρ = 0.223; p = 0.024). Cognitive (ρ = − 0.196; p = 0.048), seizures (ρ = − 0.279; p = 0.004), food-habit (ρ = − 0.199; p = 0.045), and behavioural impairments (ρ = − 0.210; p = 0.034) were negatively correlated with age (Table 4). Table 4Comorbidities associated with cerebral palsy according to cerebral palsy motor Subtype, GMFCS Level, and age: (N = 127).VariablesLanguage impairment#, n (%)(n = 100, 78.7%)Fine Motor impairment#, n (%)(n = 54, 42.5%)Personal Social impairment#, n (%)(n = 74, 58.3%)Cognitive Impairment, n (%)(n = 79, 62.2%)Seizures, n (%)(n = 58, 45.7%)Food habit impairment, n (%)(n = 36, 28.3%)Behavioural issue, n(%)(n = 26, 20.5%)Type of cerebral palsy:Spastic (n = 96)71 (74.0)42 (43.8)58 (60.4)57 (59.4)44 (45.8)26 (38.2)26 (27.1)Dyskinetic (n = 12)12 (100.0)2 (16.7)5 (41.7)12 (100.0)6 (50.0)10 (27.8)0 (0.0)Ataxic (n = 10)10 (100.0)5 (50.0)7 (70.0)5 (50.0)3 (30.0)0 (0.0)0 (0.0)Mixed (n = 9)7 (77.8)5 (55.6)4 (44.4)5 (55.6)5 (55.6)0 (0.0)0 (0.0)Likelihood Ratio Test*LR (df) = 11.77 (3), p = 0.008LR (df) = 4.58(3), p = 0.205LR (df) = 2.80(3), p = 0.423LR (df) = 12.49 (3), p = 0.006LR (df) = 1.47 (3), p = 0.689LR (df) = 18.42 (3), p = < 0.001LR (df) = 16.60 (3), p = 0.001Partial Correlation Test#ρ = 0.034,p = 0.735ρ = 0.036,p = 0.716ρ = 0.053,p = 0.597ρ = 0.054,p = 0.587ρ = 0.223,p = 0.024ρ = 0.029,p = 0.774ρ = 0.102,p = 0.307GMFCS:GMFCS I (n = 9)7 (77.8)9 (100.0)9 (100.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)GMFCS II (n = 22)13 (59.1)16 (72.7)17 (77.3)7 (31.8)4 (18.2)2 (9.1)7 (31.8)GMFCS III (n = 15)5 (33.3)7 (46.7)10 (66.7)8 (53.3)9 (60.0)0 (0.0)3 (20.0)GMFCS IV (n = 32)32 (100.0)11 (34.4)18 (56.3)23 (71.9)18 (56.3)10 (31.3)11 (34.4)GMFCS V (n = 49)43 (87.8)11 (22.4)20 (40.8)41 (83.7)27 (55.1)24 (49.0)5 (10.2)Likelihood Ratio Test*LR (df) = 36.58 (4), p = < 0.001LR (df) = 33.32(4), p = < 0.001LR (df) = 19.77 (4), p = 0.001LR (df) = 38.52 (4), p = < 0.001LR (df) = 22.78 (4), p = < 0.001LR (df) = 30.37 (4), p = < 0.001LR (df) = 12.73 (4), p = 0.013Partial Correlation Tes**ρ = 0.001,p = 0.992ρ = 0.278,p = 0.004ρ = 0.203,p = 0.039ρ = 0.367, p = < 0.001 ρ = 0.107,p = 0.280ρ = 0.257,p = 0.008ρ = 0.037,p = 0.707Age of child, y:4–5 (n = 68)57 (83.8)21 (30.9)31 (45.6)51 (75.0)40 (58.8)26(38.2)8 (11.8)6–7 (n = 36)32 (88.9)15 (41.7)24 (66.7)23 (63.9)16 (44.4)10 (27.8)12 (33.3)8–9 (n = 7)5 (71.4)4 (57.1)5 (71.4)3 (42.9)2 (28.6)0 (0.0)3 (42.9)≥ 10 (n = 16)6 (37.5)14 (87.5)14 (87.5)2 (12.5)0 (0.0)0 (0.0)3 (18.8)Likelihood Ratio Test*LR (df) = 16.56 (3), p = 0.001LR (df) = 18.62 (3), p = < 0.001LR (df) = 12.57 (3), p = 0.006LR (df) = 23.22 (3), p = < 0.001LR (df) = 25.13 (3), p = < 0.001LR (df) = 18.42 (3), p = < 0.001LR (df) = 8.65 (3), p = 0.034Partial Correlation Test†ρ = −0.113,p = 0.260ρ = −0.089,p = 0.376ρ = −0.171,p = 0.085ρ = −0.196,p = 0.048ρ = −0.279,p = 0.004ρ = −0.199,p = 0.045ρ = −0.210,p = 0.034*Univariate analysis. #Multivariable analysis adjusted for age and sex of the child; age and educational level of both parents; birth weight; receipt of antenatal care (ANC); high-risk pregnancy status; place of delivery; complications during labor; mode of delivery; crying immediately after birth; hypoxic-ischemic encephalopathy (HIE) at birth; neonatal jaundice; neonatal sepsis; neonatal seizures; breathing difficulty at birth; admission to the neonatal intensive care unit (NICU); Gross Motor Function Classification System (GMFCS); and Manual Ability Classification System (MACS) levels. **Multivariable analysis adjusted for age and sex of the child; age and educational level of both parents; birth weight; receipt of antenatal care (ANC); high-risk pregnancy status; place of delivery; complications during labor; mode of delivery; crying immediately after birth; hypoxic-ischemic encephalopathy (HIE) at birth; neonatal jaundice; neonatal sepsis; neonatal seizures; breathing difficulty at birth; admission to the neonatal intensive care unit (NICU); and type of cerebral palsy (CP). †Multivariable analysis adjusted for sex of the child; age and educational level of both parents; birth weight; receipt of antenatal care (ANC); high-risk pregnancy status; place of delivery; complications during labor; mode of delivery; crying immediately after birth; hypoxic-ischemic encephalopathy (HIE) at birth; neonatal jaundice; neonatal sepsis; neonatal seizures; breathing difficulty at birth; admission to the neonatal intensive care unit (NICU); type of cerebral palsy (CP), Gross Motor Function Classification System (GMFCS); and Manual Ability Classification System (MACS) levels. #assessed by Denver Developmental Screening Test II. ρ = Correlation Co-Efficient. Abbreviations: y: years; GMFCS: Gross Motor Function Classification System. Table 4Comorbidities associated with cerebral palsy according to cerebral palsy motor Subtype, GMFCS Level, and age: (N = 127).VariablesLanguage impairment#, n (%)(n = 100, 78.7%)Fine Motor impairment#, n (%)(n = 54, 42.5%)Personal Social impairment#, n (%)(n = 74, 58.3%)Cognitive Impairment, n (%)(n = 79, 62.2%)Seizures, n (%)(n = 58, 45.7%)Food habit impairment, n (%)(n = 36, 28.3%)Behavioural issue, n(%)(n = 26, 20.5%)Type of cerebral palsy:Spastic (n = 96)71 (74.0)42 (43.8)58 (60.4)57 (59.4)44 (45.8)26 (38.2)26 (27.1)Dyskinetic (n = 12)12 (100.0)2 (16.7)5 (41.7)12 (100.0)6 (50.0)10 (27.8)0 (0.0)Ataxic (n = 10)10 (100.0)5 (50.0)7 (70.0)5 (50.0)3 (30.0)0 (0.0)0 (0.0)Mixed (n = 9)7 (77.8)5 (55.6)4 (44.4)5 (55.6)5 (55.6)0 (0.0)0 (0.0)Likelihood Ratio Test*LR (df) = 11.77 (3), p = 0.008LR (df) = 4.58(3), p = 0.205LR (df) = 2.80(3), p = 0.423LR (df) = 12.49 (3), p = 0.006LR (df) = 1.47 (3), p = 0.689LR (df) = 18.42 (3), p = < 0.001LR (df) = 16.60 (3), p = 0.001Partial Correlation Test#ρ = 0.034,p = 0.735ρ = 0.036,p = 0.716ρ = 0.053,p = 0.597ρ = 0.054,p = 0.587ρ = 0.223,p = 0.024ρ = 0.029,p = 0.774ρ = 0.102,p = 0.307GMFCS:GMFCS I (n = 9)7 (77.8)9 (100.0)9 (100.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)GMFCS II (n = 22)13 (59.1)16 (72.7)17 (77.3)7 (31.8)4 (18.2)2 (9.1)7 (31.8)GMFCS III (n = 15)5 (33.3)7 (46.7)10 (66.7)8 (53.3)9 (60.0)0 (0.0)3 (20.0)GMFCS IV (n = 32)32 (100.0)11 (34.4)18 (56.3)23 (71.9)18 (56.3)10 (31.3)11 (34.4)GMFCS V (n = 49)43 (87.8)11 (22.4)20 (40.8)41 (83.7)27 (55.1)24 (49.0)5 (10.2)Likelihood Ratio Test*LR (df) = 36.58 (4), p = < 0.001LR (df) = 33.32(4), p = < 0.001LR (df) = 19.77 (4), p = 0.001LR (df) = 38.52 (4), p = < 0.001LR (df) = 22.78 (4), p = < 0.001LR (df) = 30.37 (4), p = < 0.001LR (df) = 12.73 (4), p = 0.013Partial Correlation Tes**ρ = 0.001,p = 0.992ρ = 0.278,p = 0.004ρ = 0.203,p = 0.039ρ = 0.367, p = < 0.001 ρ = 0.107,p = 0.280ρ = 0.257,p = 0.008ρ = 0.037,p = 0.707Age of child, y:4–5 (n = 68)57 (83.8)21 (30.9)31 (45.6)51 (75.0)40 (58.8)26(38.2)8 (11.8)6–7 (n = 36)32 (88.9)15 (41.7)24 (66.7)23 (63.9)16 (44.4)10 (27.8)12 (33.3)8–9 (n = 7)5 (71.4)4 (57.1)5 (71.4)3 (42.9)2 (28.6)0 (0.0)3 (42.9)≥ 10 (n = 16)6 (37.5)14 (87.5)14 (87.5)2 (12.5)0 (0.0)0 (0.0)3 (18.8)Likelihood Ratio Test*LR (df) = 16.56 (3), p = 0.001LR (df) = 18.62 (3), p = < 0.001LR (df) = 12.57 (3), p = 0.006LR (df) = 23.22 (3), p = < 0.001LR (df) = 25.13 (3), p = < 0.001LR (df) = 18.42 (3), p = < 0.001LR (df) = 8.65 (3), p = 0.034Partial Correlation Test†ρ = −0.113,p = 0.260ρ = −0.089,p = 0.376ρ = −0.171,p = 0.085ρ = −0.196,p = 0.048ρ = −0.279,p = 0.004ρ = −0.199,p = 0.045ρ = −0.210,p = 0.034*Univariate analysis. #Multivariable analysis adjusted for age and sex of the child; age and educational level of both parents; birth weight; receipt of antenatal care (ANC); high-risk pregnancy status; place of delivery; complications during labor; mode of delivery; crying immediately after birth; hypoxic-ischemic encephalopathy (HIE) at birth; neonatal jaundice; neonatal sepsis; neonatal seizures; breathing difficulty at birth; admission to the neonatal intensive care unit (NICU); Gross Motor Function Classification System (GMFCS); and Manual Ability Classification System (MACS) levels. **Multivariable analysis adjusted for age and sex of the child; age and educational level of both parents; birth weight; receipt of antenatal care (ANC); high-risk pregnancy status; place of delivery; complications during labor; mode of delivery; crying immediately after birth; hypoxic-ischemic encephalopathy (HIE) at birth; neonatal jaundice; neonatal sepsis; neonatal seizures; breathing difficulty at birth; admission to the neonatal intensive care unit (NICU); and type of cerebral palsy (CP). †Multivariable analysis adjusted for sex of the child; age and educational level of both parents; birth weight; receipt of antenatal care (ANC); high-risk pregnancy status; place of delivery; complications during labor; mode of delivery; crying immediately after birth; hypoxic-ischemic encephalopathy (HIE) at birth; neonatal jaundice; neonatal sepsis; neonatal seizures; breathing difficulty at birth; admission to the neonatal intensive care unit (NICU); type of cerebral palsy (CP), Gross Motor Function Classification System (GMFCS); and Manual Ability Classification System (MACS) levels. #assessed by Denver Developmental Screening Test II. ρ = Correlation Co-Efficient. Abbreviations: y: years; GMFCS: Gross Motor Function Classification System. Comorbidities associated with cerebral palsy according to cerebral palsy motor Subtype, GMFCS Level, and age: (N = 127). LR (df) = 4.58 (3), p = 0.205 LR (df) = 2.80 (3), p = 0.423 ρ = 0.034, p = 0.735 ρ = 0.036, p = 0.716 ρ = 0.053, p = 0.597 ρ = 0.054, p = 0.587 ρ = 0.223, p = 0.024 ρ = 0.029, p = 0.774 ρ = 0.102, p = 0.307 LR (df) = 33.32 (4), p = < 0.001 ρ = 0.001, p = 0.992 ρ = 0.278, p = 0.004 ρ = 0.203, p = 0.039 ρ = 0.367, p = < 0.001 ρ = 0.107, p = 0.280 ρ = 0.257, p = 0.008 ρ = 0.037, p = 0.707 ρ = −0.113, p = 0.260 ρ = −0.089, p = 0.376 ρ = −0.171, p = 0.085 ρ = −0.196, p = 0.048 ρ = −0.279, p = 0.004 ρ = −0.199, p = 0.045 ρ = −0.210, p = 0.034 *Univariate analysis. #Multivariable analysis adjusted for age and sex of the child; age and educational level of both parents; birth weight; receipt of antenatal care (ANC); high-risk pregnancy status; place of delivery; complications during labor; mode of delivery; crying immediately after birth; hypoxic-ischemic encephalopathy (HIE) at birth; neonatal jaundice; neonatal sepsis; neonatal seizures; breathing difficulty at birth; admission to the neonatal intensive care unit (NICU); Gross Motor Function Classification System (GMFCS); and Manual Ability Classification System (MACS) levels. **Multivariable analysis adjusted for age and sex of the child; age and educational level of both parents; birth weight; receipt of antenatal care (ANC); high-risk pregnancy status; place of delivery; complications during labor; mode of delivery; crying immediately after birth; hypoxic-ischemic encephalopathy (HIE) at birth; neonatal jaundice; neonatal sepsis; neonatal seizures; breathing difficulty at birth; admission to the neonatal intensive care unit (NICU); and type of cerebral palsy (CP). †Multivariable analysis adjusted for sex of the child; age and educational level of both parents; birth weight; receipt of antenatal care (ANC); high-risk pregnancy status; place of delivery; complications during labor; mode of delivery; crying immediately after birth; hypoxic-ischemic encephalopathy (HIE) at birth; neonatal jaundice; neonatal sepsis; neonatal seizures; breathing difficulty at birth; admission to the neonatal intensive care unit (NICU); type of cerebral palsy (CP), Gross Motor Function Classification System (GMFCS); and Manual Ability Classification System (MACS) levels. #assessed by Denver Developmental Screening Test II. ρ = Correlation Co-Efficient. Abbreviations: y: years; GMFCS: Gross Motor Function Classification System. Discussion This cross-sectional study, conducted over one year at a tertiary care centre, investigated the demographic, clinical, and functional profiles of children aged 4–14 years with cerebral palsy (CP). Spastic CP was the predominant subtype, affecting three-fourths of the participants, while severe gross motor impairments (GMFCS levels IV–V) were present in nearly two-thirds and severe manual ability limitations (MACS levels IV–V) in almost half. A strong association was observed between GMFCS and MACS levels, indicating that greater gross motor limitation was consistently accompanied by reduced manual ability. Perinatal and delivery-related factors—particularly home delivery, absence of crying at birth, and hypoxic-ischemic encephalopathy (HIE)—showed significant associations with functional severity, underscoring their continuing contribution to the burden of CP in low-resource settings. The median age at presentation in the present study was 5.9 years, consistent with findings from Indian studies by Suresh et al.20 in New Delhi (5 years), Sharawat et al.21 in Rishikesh (5 years), and Viswanath et al.22 in Maharashtra (6 years). Earlier diagnoses were reported by Prabha et al.23 in Lucknow (2 years), Gowda et al.24 in Bengaluru (3 years), and Bhati et al.25 in New Delhi, where most children (64.4%) were under five years of age. International studies have shown comparable trends, with Chaudhary et al.26 in Nepal and Abd Elmagid et al.4 in Egypt documenting median ages of 3 years, likely reflecting greater parental awareness and stronger early-intervention systems. In contrast, delayed presentations were observed in low-resource contexts such as Sogbossi et al.9 in Benin (7 years), Jahan et al.27 in Indonesia (8 years), and Duke et al.28 in Nigeria (9 years), attributable to systemic barriers and limited access to pediatric rehabilitation services. These findings collectively underscore the need to strengthen early-screening, referral, and diagnostic pathways in underserved regions to ensure timely initiation of rehabilitation and developmental support. In the present study, 74.0% of participants were male, consistent with the male predominance reported in several hospital-based studies, including Chaudhary et al.26 (74.5%), Bhati et al.25 (72.5%), Sharawat et al.21 (74.0%), Suresh et al.20 (66.4%), Sogbossi et al.9 (66.0%), Viswanath et al.22 (65.0%), Abd Elmagid et al.4 (64.4%), Khaleel et al.29 (63.2%), Duke et al.28 (59.0%), and Mangamba et al.30 (53.6%). This consistent male predominance may be attributed to both biological and sociocultural determinants—including the greater biological vulnerability of male infants to perinatal hypoxic–ischaemic injury, gender-related healthcare-seeking biases favouring boys, and referral bias inherent to tertiary-care studies that often capture more severe cases. The observed sex disparity likely represents a healthcare-access and survival bias rather than a true population-level difference, underscoring the importance of community-based, population-level surveillance to delineate the actual sex distribution of cerebral palsy. In the present study, only 12.6% of children attended school, underscoring substantial barriers to educational inclusion among children with cerebral palsy. This proportion was slightly higher than that reported by Jahan et al.31 in Nepal (7.7%), where participants were enrolled in mainstream or special schools, but lower than those observed by Sogbossi et al.9 (23.0%) and Chaudhary et al.26 (23.1%). School attendance in the current cohort was significantly associated with increasing age, male sex, and lower GMFCS and MACS levels, consistent with Sogbossi et al.9, who found that functional ability strongly influenced educational participation. Children without cognitive, language, or seizure impairments were more likely to attend school, echoing the findings of Duke et al.28 and Sogbossi et al.9. Similarly, those without fine-motor or personal-social impairments demonstrated higher attendance rates, highlighting the role of adaptive functioning in enabling participation. Notably, school attendance was confined to children with spastic CP (16.7%), with no enrolment among other subtypes. These findings indicate that functional independence, higher parental education, and the absence of comorbidities facilitate schooling, whereas severe motor or multiple functional limitations pose compounded barriers. Strengthening inclusive educational policies and community-based rehabilitation linkages is therefore essential to improve educational access and participation for children with CP. In the present study, spastic cerebral palsy (CP) was the most prevalent subtype (75.6%), followed by dyskinetic (9.4%), ataxic (7.9%), and mixed (7.1%) forms. This distribution aligns with findings from Indian studies by Bhati et al.25, Prabha et al.23, Gowda et al.24, and Viswanath et al.22, all of which reported spastic CP as the predominant presentation. Similar global trends have been documented by Chaudhary et al.26 in Nepal, Wanigasinghe et al.32 in Sri Lanka, Jahan et al.27 in Indonesia, Khaleel et al.29 in Iraq, Abd Elmagid et al.4 in Egypt, Sogbossi et al.9 in Benin, Duke et al.28 in Nigeria, Mangamba et al.30 in Cameroon, and Shevell et al.33 in Canada. The consistent predominance of spastic CP across diverse populations underscores its distinct neuroanatomical basis, clearer clinical recognition, and greater likelihood of tertiary referral compared with other subtypes. These findings reinforce the importance of tone management, targeted physiotherapy, and spasticity-directed rehabilitation as core components of comprehensive care for children with CP. In the present cohort, a substantial proportion of children exhibited severe functional limitations, with 63.8% classified as GMFCS levels IV–V. This was comparable to the findings of Viswanath et al.22 (62.2%) and Jahan et al.27 in Indonesia (60.0%), but higher than those reported by Sogbossi et al.9 (54.0%), Chaudhary et al.26 (36.4%), Shevell et al.33 (34.0%), Duke et al.28 (28.0%), and Carnahan et al.34 in Sweden (25.9%). Conversely, it was lower than that documented by Prabha et al.23 (75.4%). Similarly, 45.0% of participants were classified as MACS levels IV–V, comparable to Sogbossi et al.9 (45%) and Jahan et al.27 (43.2%), but higher than Carnahan et al.34 (23.7%) and Duke et al.28 (23.0%). The variation in severity proportions across studies likely reflects differences in healthcare access, timing of diagnosis, and rehabilitation referral systems. The high prevalence of severe impairment in this tertiary-care cohort may indicate delayed diagnosis, underutilization of community-based rehabilitation, and referral bias, underscoring the urgent need to strengthen early screening, parent education, and intervention programs within primary care. In the present study, the severity of MACS classifications increased proportionally with higher GMFCS levels, demonstrating a strong association between gross motor and manual function. This observation is consistent with Sogbossi et al.9, who also reported a close alignment between the two scales. Carnahan et al.34 similarly identified a moderate correlation between GMFCS and MACS levels, particularly within specific functional subgroups, indicating partial but clinically meaningful overlap between motor and manual ability domains rather than complete concordance (κ = 0.35; 95% CI: 0.27–0.41). Furthermore, spastic cerebral palsy predominated among children with severe gross motor impairment, corroborating the findings of Viswanath et al.22 and Sogbossi et al.9, both of whom reported greater severity within the spastic subtype. These results collectively highlight that motor and manual functional limitations in CP often progress in tandem, particularly among children with spastic presentations, underscoring the need for integrated rehabilitation strategies addressing both gross and fine motor domains. A significant association was observed between children’s age and GMFCS levels, with younger children exhibiting greater functional impairment. This finding contrasts with the observations of Sogbossi et al.9, who reported no such association. However, the declining proportion of severely affected children with increasing age in our study mirrors their trend, likely reflecting functional improvement through maturation and therapy or a survival bias, wherein children with severe motor limitations (GMFCS IV–V) may have reduced survival into later childhood. This phenomenon has been reported in longitudinal studies35,36, which demonstrate higher mortality risk and shorter life expectancy among severely affected children with CP. Although mortality data from our centre were not available to confirm this pattern, the observed distribution suggests that both survival bias and rehabilitation-related functional adaptation may contribute to the age-related decline in severe impairment. These findings underscore the importance of early identification, timely rehabilitation, and longitudinal functional monitoring to optimize outcomes and alter developmental trajectories in children with CP. Several factors showed a significant association with severe gross motor impairment (GMFCS levels IV–V), including parental age between 20 and 29 years, high birth weight (> 4000 g), home delivery, absence of crying at birth, seizures at birth, and hypoxic–ischemic encephalopathy (HIE). These results are consistent with Sogbossi et al.9, who also identified perinatal complications as major determinants of motor severity. Children with higher GMFCS levels demonstrated a greater prevalence of language, fine-motor, personal–social, cognitive, and behavioural impairments, as well as seizures and feeding difficulties, indicating a compounded burden of comorbidities in severe CP. In contrast, all children with GMFCS I exhibited normal cognitive, behavioural, and feeding functions, suggesting that better motor performance may be protective against secondary developmental deficits. Language impairment was most frequent among younger children (< 10 years), whereas cognitive impairment, seizures, and feeding difficulties showed improvement with increasing age. However, language and behavioural problems persisted irrespective of age. Behavioural issues were observed exclusively in spastic CP, while feeding impairments were confined to spastic and dyskinetic types. Collectively, these findings highlight the interconnected nature of motor severity and neurodevelopmental comorbidities, emphasizing the need for multidisciplinary, individualized management strategies that address both functional and cognitive domains. In the present study, language impairment emerged as the most prevalent comorbidity across all types of cerebral palsy, followed by cognitive impairment and seizures. Similar patterns were reported by Mangamba et al.30, Duke et al.28, and Jahan et al.27 in Indonesia, who identified language and speech difficulties as major challenges in children with CP. Conversely, Sogbossi et al.9, Viswanath et al.22, and Chaudhary et al.26 identified cognitive impairment as the most frequent comorbidity, while Bhati et al.25 and Gowda et al.24 highlighted seizures as prominent associated conditions. Although visual disorders were not observed in our cohort, they were reported as common comorbidities in studies by Khaleel et al.29 and Wanigasinghe et al.32, suggesting contextual variability in comorbidity patterns across populations. Collectively, these findings underscore the multifaceted nature of cerebral palsy, emphasizing that both motor and non-motor impairments contribute substantially to functional disability. This highlights the necessity of comprehensive, multidisciplinary care models that integrate neurodevelopmental, cognitive, and rehabilitative interventions to optimize quality of life and long-term outcomes. This study has certain limitations that warrant consideration. First, being hospital-based and conducted in a tertiary care setting, the study population likely overrepresents children with more severe or symptomatic cerebral palsy, thereby limiting the generalizability of findings to milder or community-dwelling cases. Second, antenatal and perinatal histories were largely caregiver-reported and may have been influenced by recall bias, potentially affecting the accuracy of exposure assessment. Third, cognitive function was evaluated using the Denver Developmental Screening Test II (DDST-II), a validated screening tool; however, formal intelligence quotient (IQ) testing was not performed, restricting the classification of intellectual disability based on standardized psychometric criteria. Furthermore, the DDST-II does not provide a detailed neuropsychological profile, which may limit comparability with studies employing diagnostic cognitive assessments. Fourth, visual impairments, though frequently reported in children with CP, were not systematically assessed due to logistical constraints in the outpatient setting. Fifth, the limited availability of assistive devices such as orthoses and mobility aids in this resource-constrained environment may have led to an overestimation of functional impairment, as higher GMFCS classifications may partly reflect environmental rather than intrinsic motor limitations. Finally, given the modest sample size and exploratory design, multivariable logistic regression and adjustments for multiple comparisons were not applied, which may increase the potential for Type I error and residual confounding. Despite these limitations, the study contributes valuable insights into the functional severity and comorbidity patterns among children with CP in a low-resource eastern Indian setting, addressing a crucial evidence gap and reinforcing the need for community-level screening, early intervention, and service integration. Conclusion This study reaffirms spastic cerebral palsy as the predominant subtype, most frequently associated with severe gross and fine motor impairments. The burden of language, cognitive, and seizure-related comorbidities was considerable and had a pronounced impact on functional independence and school participation. Educational inclusion was more likely among children with milder GMFCS and MACS classifications and in the absence of major comorbidities such as cognitive, language, fine-motor, personal–social impairments, and seizures. Several perinatal and sociodemographic factors—including parental age and education, birth weight, high-risk pregnancy, delivery characteristics, and neonatal complications such as hypoxic–ischemic encephalopathy, seizures, and jaundice—were identified as key determinants of motor severity. These findings underscore the urgent need to strengthen perinatal care systems, facilitate early diagnosis, and expand multidisciplinary rehabilitation and inclusive education services to mitigate disability and improve quality of life among children with cerebral palsy, particularly in resource-constrained settings. Fig. 1Distribution of the study participants with cerebral palsy (CP) according to their MACS and GMFCS levels (A). Distribution of MACS (B) and CP subtype (C) by GMFCS (percentage of total number of each GMFCS level). Distribution of GMFCS levels by children’s age (D). GMFCS, Gross Motor Function Classification System; MACS, Manual Ability Classification System. (N = 127). y Years, GMFCS Gross motor function classification system, MACS Manual ability classification system. Distribution of the study participants with cerebral palsy (CP) according to their MACS and GMFCS levels (A). Distribution of MACS (B) and CP subtype (C) by GMFCS (percentage of total number of each GMFCS level). Distribution of GMFCS levels by children’s age (D). GMFCS, Gross Motor Function Classification System; MACS, Manual Ability Classification System. (N = 127). y Years, GMFCS Gross motor function classification system, MACS Manual ability classification system. Fig. 2Distribution of children with cerebral palsy (CP) according to their GMFCS levels grouped as “independent walkers” (level I and II) and “Non-Walkers” (level III and V) and their ages. (n = 127). y Years Distribution of children with cerebral palsy (CP) according to their GMFCS levels grouped as “independent walkers” (level I and II) and “Non-Walkers” (level III and V) and their ages. (n = 127). y Years